The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 20, 2016
Filed:
Aug. 23, 2012
Applicants:
Gregory A. Poland, Rochester, MN (US);
Richard B. Kennedy, Rochester, MN (US);
Inventors:
Gregory A. Poland, Rochester, MN (US);
Richard B. Kennedy, Rochester, MN (US);
Assignee:
Mayo Foundation for Medical Education and Research, Rochester, MN (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/285 (2006.01); A61K 38/00 (2006.01); A61K 39/295 (2006.01); C12N 7/00 (2006.01); C12N 15/86 (2006.01); A61K 39/12 (2006.01); C07K 14/005 (2006.01);
U.S. Cl.
CPC ...
A61K 39/285 (2013.01); A61K 38/00 (2013.01); A61K 39/12 (2013.01); A61K 39/295 (2013.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); C12N 15/86 (2013.01); C12N 2710/24122 (2013.01); C12N 2710/24134 (2013.01);
Abstract
This document provides methods and materials related to polypeptides present in a vaccinia virus (e.g., membrane proteins such as vaccinia virus B5R, L1R, A33R, or A27L polypeptides). For example, methods for generating a vaccine comprising one or more of vaccinia virus polypeptides disclosed herein for preventing or treating Orthopoxvirus infection are provided. In addition, kits related to the use of vaccinia polypeptides are provided.